Froedtert & the Medical College of Wisconsin/ThedaCare | Strategic Alliance Partners

Study coauthor William J. Peppard, PharmD, discusses which patients may benefit most from suzetrigine after knee replacement and how pharmacists can address cost and access barriers to postoperative treatment.

In an interview with Pharmacy Times, William J. Peppard, PharmD, pain stewardship coordinator at Froedtert & the Medical College of Wisconsin and coauthor of a retrospective suzetrigine study, discusses findings suggesting that the nonopioid medication could help reduce postoperative opioid prescribing after total knee arthroplasty.

In a Pharmacy Times interview, study coauthor William J. Peppard, PharmD, discusses the association between suzetrigine and fewer opioid refills after knee replacement, the limits of the evidence, and the access barriers pharmacists can help patients navigate.

Team-based hypertension care puts pharmacists and home blood pressure monitoring at the front line, boosting control rates and saving lives and costs.

Experts discuss real-world BTCE challenges, toxicity monitoring, and evolving pharmacy practice.

This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.

We should begin to refer to these pharmacists in direct-to-career paths accordingly as “primary care pharmacists.”

James McCloskey, MD, and Danielle Marcotulli, APN, RN, MSN, FNP-BC, AOCNP give a brief synopsis of AML, including its definition, the different types of the condition, and a typical patient’s journey.

Among the most important members of the 340B team of a covered entity (CE) are the software vendors.

Certain institutional providers are required to file a Medicare cost report annually to CMS, which uses that information to set prospective payment rates and determine if Medicare overpaid or underpaid a given institution during the submitted fiscal year.